Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1017/S0963180120000481 http://scihub22266oqcxt.onion/10.1017/S0963180120000481 32498751!7373824!32498751     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Camb+Q+Healthc+Ethics 2021 ; 30 (1): 51-58 Nephropedia Template TP {{tp|p=32498751|t=2021. Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps |pdf=|usr=}}{{32498751}} gab.com Text Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps JO: Camb Q Healthc Ethics http://www.kidney.de/pget.php?&tw=1&pmid=32498751 #FOAvip While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing (drug repositioning). However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When drug repurposing is employed in emergency situations, the fairness of resource distribution becomes an issue that requires careful ethical consideration.This paper examines the drug repurposing in emergency situations focusing on the fairness using Japanese cases. Ethical issues under these circumstances addressed by the authors include: maintaining the evidence level, integrity of clinical research ethics, and voluntary consent by original indication patients. In order to address these issues, they argue that rapid accumulation of ethically and scientifically valid evidence is required, as is obtaining information on resource quantity. Twit Text FOAVip Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps ????Camb Q Healthc Ethics http://www.kidney.de/pget.php?&tw=1&pmid=32498751 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32498751 #FOAvip English Wikipedia <ref>{{Cite pmid|32498751}}</ref> Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps #MMPMID32498751 Ino H; Nakazawa E; Akabayashi A Camb Q Healthc Ethics 2021[Jan]; 30 (1): 51-58 PMID32498751show ga While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing (drug repositioning). However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When drug repurposing is employed in emergency situations, the fairness of resource distribution becomes an issue that requires careful ethical consideration.This paper examines the drug repurposing in emergency situations focusing on the fairness using Japanese cases. Ethical issues under these circumstances addressed by the authors include: maintaining the evidence level, integrity of clinical research ethics, and voluntary consent by original indication patients. In order to address these issues, they argue that rapid accumulation of ethically and scientifically valid evidence is required, as is obtaining information on resource quantity. |*COVID-19 Drug Treatment[MESH] |Drug Repositioning/*ethics[MESH] |Humans[MESH] |Resource Allocation/ethics[MESH]Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps (epmc).pdf DeepDyve Pubget Overpricing